Microbiome Therapeutic Lactiplantibacillus plantarum PMC105 for Systemic Carbapenem-Resistant Enterobacteriaceae Infections: Oral and Inhalation Efficacy In Vivo.

J Microbiol Biotechnol · 2025 · PMC12790992 · PMID 41466108

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

plantarum PMC105 reduced the bacterial burden and showed a trend toward improved survival compared with the CRKP-infected group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Microbiome Therapeutic <i>Lactiplantibacillus plantarum</i> PMC105 for Systemic Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections: Oral and Inhalation Efficacy <i>In Vivo</i>.

The sentences